Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07420361
Eligibility Criteria:
Inclusion criteria
* Age between 55 and 80 years old
* diagnosis of early to intermediate stage dAMD (based on AREDS criteria)
* presence of RPD
* Treated with scleral Lutein Iontophoresis
Exclusion Criteria:
* GA or MNV in the included eye
* any prior or any ongoing medical or surgical treatment of the included eye (including intravitreal injections, oral supplementation of lutein, zeaxanthin and or high dietary intake of antioxidants)
* smokers (consummation of more than 20 cigarettes per day)
* history of treatment with drugs with a well-known possible ophthalmic side-effect
* known eye diseases such glaucoma, acute or chronic uveitis, advanced cataract, stage 4 dry eye disease or any opacities of the ocular media that do not permit high-quality imaging examinations
* manifest refraction outside of -6 and +4 dioptres
* BCVA \< 40 EDTRS letters.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
80 Years
Study:
NCT07420361
Study Brief:
Protocol Section:
NCT07420361